Bo Hou

1.9k total citations · 2 hit papers
17 papers, 1.7k citations indexed

About

Bo Hou is a scholar working on Immunology, Biomedical Engineering and Oncology. According to data from OpenAlex, Bo Hou has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Biomedical Engineering and 8 papers in Oncology. Recurrent topics in Bo Hou's work include Nanoplatforms for cancer theranostics (9 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (6 papers). Bo Hou is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (6 papers). Bo Hou collaborates with scholars based in China and Macao. Bo Hou's co-authors include Haijun Yu, Yaping Li, Bing Feng, Zhiai Xu, Madiha Saeed, Dangge Wang, Lei Zhou, Fangyuan Zhou, Tingting Wang and Yuting Ma and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Bo Hou

17 papers receiving 1.7k citations

Hit Papers

Binary Cooperative Prodrug Nanoparticles Improve Immunoth... 2018 2026 2020 2023 2018 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
    2018 404 citations Bing Feng, Fangyuan Zhou et al. Advanced Materials profile →
  2. Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
    2022 143 citations Jing Gao, Bo Hou et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Hou China 14 1.2k 782 519 466 423 17 1.7k
Sara Musetti United States 12 821 0.7× 547 0.7× 599 1.2× 396 0.8× 526 1.2× 15 1.6k
Kyle C. Roche United States 14 828 0.7× 556 0.7× 550 1.1× 540 1.2× 410 1.0× 20 1.6k
Qi Zhuang China 10 865 0.7× 540 0.7× 416 0.8× 213 0.5× 178 0.4× 13 1.3k
Suah Yang South Korea 18 718 0.6× 310 0.4× 447 0.9× 279 0.6× 431 1.0× 23 1.2k
Haihua Xiao China 22 1.0k 0.8× 369 0.5× 522 1.0× 220 0.5× 279 0.7× 39 1.6k
Xinghui Si China 19 622 0.5× 470 0.6× 386 0.7× 259 0.6× 346 0.8× 37 1.2k
Youshi Zheng China 23 673 0.6× 452 0.6× 565 1.1× 281 0.6× 203 0.5× 43 1.4k
Zhaohan Wei China 15 706 0.6× 426 0.5× 526 1.0× 196 0.4× 283 0.7× 23 1.3k
Yudi Xu China 15 583 0.5× 513 0.7× 380 0.7× 217 0.5× 291 0.7× 35 1.1k
Ying‐Li Luo China 22 625 0.5× 440 0.6× 1.1k 2.1× 256 0.5× 407 1.0× 37 1.9k

Countries citing papers authored by Bo Hou

Since Specialization
Citations

This map shows the geographic impact of Bo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hou more than expected).

Fields of papers citing papers by Bo Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hou. The network helps show where Bo Hou may publish in the future.

Co-authorship network of co-authors of Bo Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hou. A scholar is included among the top collaborators of Bo Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hou. Bo Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhou, Huiling, Bo Hou, Lujia Huang, et al.. (2025). De Novo Design of Structure‐Tunable Multivalent Targeting Chimeras for Tumor‐Targeted PD‐L1 Degradation and Potentiated Cancer Immunotherapy. Angewandte Chemie International Edition. 64(27). e202504233–e202504233. 1 indexed citations
2.
Chen, Xinglong, Haiying Zhang, Zhou Tang, et al.. (2024). Cytotoxic diterpenoids from the roots of Euphorbia jolkinii Boiss against human pancreatic cancer SW1990 cells by regulating the expressions of Bcl-2, Bax, and Caspase-3 proteins. Arabian Journal of Chemistry. 17(12). 106012–106012. 1 indexed citations
3.
Zhou, Mengxue, Jiaxing Pan, Hui Wang, et al.. (2023). Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy. Nature Communications. 14(1). 3593–3593. 53 indexed citations
4.
Gao, Jing, Bo Hou, Qiwen Zhu, et al.. (2022). Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy. Nature Communications. 13(1). 4318–4318. 143 indexed citations breakdown →
5.
Li, Tianliang, Rundi Song, Fang Sun, et al.. (2022). Bioinspired magnetic nanocomplexes amplifying STING activation of tumor-associated macrophages to potentiate cancer immunotherapy. Nano Today. 43. 101400–101400. 28 indexed citations
6.
Ye, Jiayi, Bo Hou, Madiha Saeed, Zhiai Xu, & Haijun Yu. (2022). Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy. Accounts of Materials Research. 3(7). 697–708. 24 indexed citations
7.
Hou, Bo, Jiayi Ye, Junhao Li, Zhiai Xu, & Haijun Yu. (2022). In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy. Nano Today. 47. 101661–101661. 17 indexed citations
8.
Ye, Jiayi, Bo Hou, Fangmin Chen, et al.. (2021). Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy. Acta Pharmaceutica Sinica B. 12(6). 2695–2709. 47 indexed citations
9.
Hou, Bo, et al.. (2020). Computer Vision Tool-Setting System of Numerical Control Machine Tool. Sensors. 20(18). 5302–5302. 12 indexed citations
10.
Hou, Bo, Lei Zhou, Hui Wang, et al.. (2020). Engineering Stimuli‐Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy. Advanced Materials. 32(12). e1907210–e1907210. 125 indexed citations
11.
Zhou, Lei, Bo Hou, Dangge Wang, et al.. (2020). Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer. Nano Letters. 20(6). 4393–4402. 123 indexed citations
12.
Hu, Xianli, Bo Hou, Zhiai Xu, et al.. (2020). Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer. Advanced Science. 7(8). 1903332–1903332. 93 indexed citations
13.
Gao, Jing, Hanwu Zhang, Fengqi Zhou, et al.. (2020). Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition. Chinese Chemical Letters. 32(6). 1929–1936. 39 indexed citations
14.
Feng, Bing, Bo Hou, Zhiai Xu, et al.. (2019). Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy. Advanced Materials. 31(40). e1902960–e1902960. 230 indexed citations
15.
Gao, Ang, Binfan Chen, Jing Gao, et al.. (2019). Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer. Nano Letters. 20(1). 353–362. 180 indexed citations
16.
Feng, Bing, et al.. (2019). Enhancing Triple Negative Breast Cancer Immunotherapy by ICG‐Templated Self‐Assembly of Paclitaxel Nanoparticles. Advanced Functional Materials. 30(6). 187 indexed citations
17.
Feng, Bing, Fangyuan Zhou, Bo Hou, et al.. (2018). Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment. Advanced Materials. 30(38). e1803001–e1803001. 404 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Musetti Breakdown of academic impact, for papers by Kyle C. Roche Breakdown of academic impact, for papers by Qi Zhuang Breakdown of academic impact, for papers by Suah Yang Breakdown of academic impact, for papers by Haihua Xiao Breakdown of academic impact, for papers by Xinghui Si Breakdown of academic impact, for papers by Youshi Zheng Breakdown of academic impact, for papers by Zhaohan Wei Breakdown of academic impact, for papers by Yudi Xu Breakdown of academic impact, for papers by Ying‐Li Luo
Rankless by CCL
2026